with our investigational PCSK9-inihibitor alirocumab. "PCSK9 inhibition represents an exciting new development in particular for those patients." Despite benefits with currently available lipid ...

the most successful PCSK9 inhibitors have been biologics — to date, two monoclonal antibodies (mAbs; alirocumab and evolocumab) and a small interfering RNA (siRNA; inclisiran). [Robinson JG.

Sanofi and Regeneron have announced positive results from trials of novel drug alirocumab ... to the US FDA last week for its rival PCSK9 inhibitor drug evolocumab. One of the four, the ODYSSEY ...

Thus, combining PCSK9 inhibitors with anti-PD-1/PD-L1 immunotherapy may be a new strategy to improve antitumor effects. Proprotein convertases (PCs) are a unique class of serine proteinases.

Allergan was running a long-term study on silicone breast implants. I had always wanted a more feminine body like the girls in the magazines, so I joined and got implants. They never followed up with ...